Publications en collaboration avec des chercheurs de Centro de Investigación Cooperativa en Biomateriales (9)

2023

  1. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  2. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

2020

  1. Na+ controls hypoxic signalling by the mitochondrial respiratory chain

    Nature, Vol. 586, Núm. 7828, pp. 287-291

  2. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension

    FASEB Journal, Vol. 34, Núm. 10, pp. 13626-13640

  3. Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation

    Nature Immunology, Vol. 21, Núm. 2, pp. 135-144

2018

  1. HIV transgene expression impairs K+ channel function in the pulmonary vasculature

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 315, Núm. 5, pp. L711-L723

  2. Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage

    Redox Biology, Vol. 15, pp. 143-158

  3. Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 4, pp. 702-708